𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin-2 therapy for advanced chronic myeloid leukemia

✍ Scribed by Goodman, M; Spector, N; Rodrigues, G; Cassileth, P A

Book ID
110054008
Publisher
Nature Publishing Group
Year
1998
Tongue
English
Weight
72 KB
Volume
12
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment options for chronic myeloid le
Treatment options for chronic myeloid leukemia
✍ Tanaka, Maria Florencia; Kantarjian, Hagop; Cortes, Jorge; Ohanian, Maro; Jabbou πŸ“‚ Article πŸ“… 2012 πŸ› Informa plc 🌐 English βš– 292 KB
First-line therapy for chronic myeloid l
First-line therapy for chronic myeloid leukemia: Past, present, and future
✍ Carolina Pavlovsky; Hagop Kantarjian; Jorge E. Cortes πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 326 KB

## Abstract The development of Bcr‐Abl tyrosine kinase inhibitors has dramatically changed the prognosis of patients with newly diagnosed chronic myeloid leukemia (CML). Standard‐dose imatinib (400 mg/day in chronic phase, 600 mg/day in advanced CML) now dominates the management of this disease, pr